Pharmacokinetics, efficacy, and safety of a plasma-derived VWF/FVIII concentrate (VONCENTO) for on-demand and prophylactic treatment in patients with von Willebrand disease (SWIFT-VWD study)

Published 2016 View Full Article

Authors

Keywords

Journal

BLOOD COAGULATION & FIBRINOLYSIS

Volume -, Issue -, Pages 1

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2016-05-20

DOI

10.1097/mbc.0000000000000568

Ask authors/readers for more resources

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

BLOOD COAGULATION & FIBRINOLYSIS

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Create your own webinar

Ask a Question. Answer a Question.